We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.

ImmunoPrecise Antibodies (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

Each year, snake bites kill upwards of 100,000 people and permanently disable hundreds of thousands more, according to ...

AI is poised to revolutionize drug discovery, but uncertainty in developing protectable IP in this emerging field creates a host of potential ...

ImmunoPrecise Antibodies (IPA) announced the launch of its AI-powered pipeline of both optimized and new therapeutics. By combining advanced ...

ImmunoPrecise Antibodies Ltd. (IPA ... and patient satisfaction in diabetes treatment. These AI-designed therapeutics aim to improve upon current GLP-1 therapies, which are widely used for ...